Wenjia H. Yang
Beijing Key Laboratory Of Innovative Drug And Device Translation In Endocrine And Metabolic Diseases
Beijing, 100044, China
Beijing, 100044, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 79 publications
Risk factor analysis and predictive model construction and evaluation of fractional uric acid excretion in Chinese inpatients with type 2 diabetes.
Journal: Scientific reports
Published: May 07, 2026
Anti-obesity medications and cognitive disorder risk: a discrepancy between RCTs and real-world evidence.
Journal: Frontiers in pharmacology
Published: April 18, 2026
Intensive blood pressure reduction but an increased risk of peripheral arterial disease: a systematic review and meta-analysis of randomized controlled trials.
Journal: Annals of medicine
Published: December 13, 2025
Control of the cardiovascular risk factors in patients with type 2 diabetes mellitus in China in 2023-2024.
Journal: Diabetes, obesity & metabolism
Published: September 16, 2025
The association between glucagon-like peptide-1 receptor agonists and reported musculoskeletal adverse events: a systematic review and meta-analysis of randomized controlled trials.
Journal: Therapeutic advances in musculoskeletal disease
Published: August 26, 2025
Anti-diabetic medications and cancer: links beyond glycemic and body weight control.
Journal: Precision clinical medicine
Published: July 29, 2025
Characterizing echocardiographic abnormalities and their associated factors in patients with type 1 diabetes: a cross-sectional study.
Journal: Cardiovascular diabetology
Published: June 28, 2025
Weight Loss, Obesity Medication, and Risk of Obesity-Associated Cancer: A Meta-Analysis of Randomized Controlled Trials.
Journal: Obesity (Silver Spring, Md.)
Published: June 15, 2025
PCSK9 Inhibitor and Potential Decreased Risk of Neoplasms, Especially in Females: A Meta-Analysis.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: May 11, 2025
Glucagon-like peptide-1 receptor agonist treatment associated weight fluctuation and influencing factors in patients with overweight or obesity.
Journal: Diabetes, obesity & metabolism
Published: February 28, 2025
Last Updated: 09/26/2026